ArticleOncology letters2022

Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA.

Jinju Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.